KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Minority Interest (2016 - 2021)

Idexx Laboratories has reported Minority Interest over the past 13 years, most recently at $706000.0 for Q3 2021.

  • Quarterly results put Minority Interest at $706000.0 for Q3 2021, up 30.98% from a year ago — trailing twelve months through Sep 2021 was $706000.0 (up 30.98% YoY), and the annual figure for FY2020 was $707000.0, up 100.85%.
  • Minority Interest for Q3 2021 was $706000.0 at Idexx Laboratories, down from $763000.0 in the prior quarter.
  • Over the last five years, Minority Interest for IDXX hit a ceiling of $763000.0 in Q2 2021 and a floor of $178000.0 in Q1 2017.
  • Median Minority Interest over the past 5 years was $304000.0 (2019), compared with a mean of $396263.2.
  • Biggest five-year swings in Minority Interest: rose 4.33% in 2018 and later soared 100.85% in 2020.
  • Idexx Laboratories' Minority Interest stood at $264000.0 in 2017, then increased by 6.06% to $280000.0 in 2018, then increased by 25.71% to $352000.0 in 2019, then soared by 100.85% to $707000.0 in 2020, then fell by 0.14% to $706000.0 in 2021.
  • The last three reported values for Minority Interest were $706000.0 (Q3 2021), $763000.0 (Q2 2021), and $739000.0 (Q1 2021) per Business Quant data.